Testicular Germ Cell Tumor Clinical Trial
Official title:
A Multicentric Case-control Study to Assess the Association Between Environmental, Domestic and Occupational Exposures During Antenatal and Early Postnatal Periods and the Risk to Develop a Testicular Germ Cell Tumor During Adulthood
The incidence of testicular germ cell tumors, the most common cancer in men aged 15 to 45
years, has doubled in France in 30 years. Reasons remain unclear but a role of environmental
factors, especially during critical periods of development, is strongly suspected. Reliable
data on environmental exposure during this critical period are sparse.The discordant findings
and the limitations of available studies underline the importance to conduct studies with
sufficient statistical power to detect risk due to exposures during critical windows of
vulnerability.
We conduct a multicentric case-control study to assess this association. Cases and controls
will be enrolled during a 18-month period. They will be interviewed by professional telephone
interviewers about their occupational and residential history and about their domestic
exposure to pesticides and other nuisances.
An optional biological study to assess genetic polymorphisms known to be associated with
testicular cancer will be proposed to every cases and controls.
Mothers (or close relative) of cases and controls will also be contacted (with son's
agreement). If they agree to participate, they will also be interviewed about antenatal and
early life exposure of their sons to pesticides and other nuisances.
Cases will be matched up with 2 controls (one of each group) both on age (+/- 2 years) and on
recruiting center.
Environmental exposure to pesticides will be assessed from subject's residential history,
using a Geographic Information System.
Occupational exposure to pesticides and other nuisances will be assessed by an industrial
hygienist who will be in charge to encode all subjects and mothers' occupations.
Domestic exposure to pesticides will be assessed from type, target and frequency of domestic
pesticide use.
Based on these 3 sources of exposure, a score of exposition will be calculated for each case
and each control.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00006126 -
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
|
Phase 1 | |
Completed |
NCT00003173 -
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
|
Phase 2 | |
Completed |
NCT00002596 -
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
|
Phase 3 | |
Not yet recruiting |
NCT03448822 -
Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour
|
||
Completed |
NCT01433224 -
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
|
N/A | |
Recruiting |
NCT01172912 -
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
|
Phase 2 | |
Completed |
NCT00293384 -
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
|
N/A | |
Active, not recruiting |
NCT00003643 -
Combination Chemotherapy in Treating Men With Germ Cell Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT00003107 -
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
|
Phase 1 | |
Completed |
NCT00019331 -
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
|
Phase 2 | |
Completed |
NCT00002515 -
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
|
Phase 2 | |
Recruiting |
NCT06133699 -
Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors
|
N/A | |
Recruiting |
NCT05670938 -
Follow-up After Surgery for Testicular Cancer
|
||
Active, not recruiting |
NCT00104676 -
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
|
Phase 3 | |
Recruiting |
NCT00551122 -
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT00002508 -
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT00003800 -
Diagnostic Study of Patients With Stage I Testicular Cancer
|
N/A | |
Terminated |
NCT05012397 -
Milademetan in Advanced/Metastatic Solid Tumors
|
Phase 2 | |
Completed |
NCT00007813 -
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
|
Phase 1 |